Andere talen Neurobiological Technologies, Inc.

Aandelen

NTII

US64124W3043

Vertraagde tijd OTC Markets Andere beurzen 20:29:56 17-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,000001 ^USD	0,00%		0,00%	0,00%

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Neurobiological Technologies Inc. Announces Extraordinary Dividend, Payable on December 27, 2012	17-12-12
NEUROBIO TECH : Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share	23-11-09
NEUROBIO TECH : Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and Dissolution	28-10-09
NEUROBIO TECH : Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital Market	19-10-09
NEUROBIO TECH : Neurobiological Technologies Receives Nasdaq Closing Bid Price Notification	17-09-09
NEUROBIO TECH : Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Children's Medical Center	12-08-09
NEUROBIOLO TCHNLGS : Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results	08-05-09
NEUROBIOLO TCHNLGS : Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine	01-05-09
NEUROBIOLO TCHNLGS : Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of Company	26-03-09
NEUROBIOLO TCHNLGS : Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results	12-02-09
NEUROBIOLO TCHNLGS : Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine	03-02-09
NEUROBIOLO TCHNLGS : Neurobiological Technologies Announces Suspension of Viprinex Development	13-01-09
NEUROBIOLO TCHNLGS : Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis	17-12-08
NEUROBIOLO TCHNLGS : Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results	06-11-08
NEUROBIOLO TCHNLGS : Neurobiological Technologies to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York on November 10	05-11-08
NEUROBIOLO TCHNLGS : Neurobiological Technologies Sets Date for First Quarter Financial Results	04-11-08
NEUROBIOLO TCHNLGS : Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of Memantine	03-11-08
NEUROBIOLO TCHNLGS : Neurobiological Technologies to Present at the BIO Investor Forum in San Francisco on October 30, 2008	27-10-08
NEUROBIOLO TCHNLGS : Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data	13-10-08
NEUROBIOLO TCHNLGS : Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program	10-10-08

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Neurobiological Technologies, Inc.

Aandelen

NTII

US64124W3043

Andere talen

Filters